Click for best price
Colorectal Cancer Diagnostics & Therapeutics Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics & Therapeutics. This report contains market size and forecasts of Colorectal Cancer Diagnostics & Therapeutics in global, including the following market information:
Global Colorectal Cancer Diagnostics & Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Colorectal Cancer Diagnostics & Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Colorectal Cancer Diagnostics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Diagnostics & Therapeutics include Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics and Exact Science Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Colorectal Cancer Diagnostics & Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Diagnostics & Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Colorectal Cancer Diagnostics & Therapeutics Market Segment Percentages, by Type, 2022 (%)
Colorectal Cancer Diagnostics
Colorectal Cancer Therapeutics
Global Colorectal Cancer Diagnostics & Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Colorectal Cancer Diagnostics & Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Others
Global Colorectal Cancer Diagnostics & Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Colorectal Cancer Diagnostics & Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Diagnostics & Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Colorectal Cancer Diagnostics & Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Colorectal Cancer Diagnostics & Therapeutics, market overview.
Chapter 2: Global Colorectal Cancer Diagnostics & Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnostics & Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colorectal Cancer Diagnostics & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Colorectal Cancer Diagnostics & Therapeutics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Colorectal Cancer Diagnostics & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colorectal Cancer Diagnostics & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colorectal Cancer Diagnostics & Therapeutics Overall Market Size
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size: 2022 VS 2030
2.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colorectal Cancer Diagnostics & Therapeutics Players in Global Market
3.2 Top Global Colorectal Cancer Diagnostics & Therapeutics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Diagnostics & Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Colorectal Cancer Diagnostics & Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Diagnostics & Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Colorectal Cancer Diagnostics & Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Diagnostics & Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Colorectal Cancer Diagnostics
4.1.3 Colorectal Cancer Therapeutics
4.2 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.3.2 US Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.3.3 Canada Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.3.4 Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.4.2 Germany Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.3 France Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.4 U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.5 Italy Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.6 Russia Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.8 Benelux Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.5.2 China Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.3 Japan Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.4 South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.6 India Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.6.2 Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.6.3 Argentina Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.7.2 Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7.3 Israel Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7.5 UAE Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
7 Colorectal Cancer Diagnostics & Therapeutics Companies Profiles
7.1 Biocept
7.1.1 Biocept Company Summary
7.1.2 Biocept Business Overview
7.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.1.4 Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Biocept Key News & Latest Developments
7.2 Cancer Genetics
7.2.1 Cancer Genetics Company Summary
7.2.2 Cancer Genetics Business Overview
7.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.2.4 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Cancer Genetics Key News & Latest Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Company Summary
7.3.2 Foundation Medicine Business Overview
7.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.3.4 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Foundation Medicine Key News & Latest Developments
7.4 Sysmex Corporation
7.4.1 Sysmex Corporation Company Summary
7.4.2 Sysmex Corporation Business Overview
7.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.4.4 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Sysmex Corporation Key News & Latest Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Company Summary
7.5.2 Danaher Corporation Business Overview
7.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.5.4 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Danaher Corporation Key News & Latest Developments
7.6 Epigenomics
7.6.1 Epigenomics Company Summary
7.6.2 Epigenomics Business Overview
7.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.6.4 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Epigenomics Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.7.4 Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Illumina Key News & Latest Developments
7.8 Rosetta Genomics
7.8.1 Rosetta Genomics Company Summary
7.8.2 Rosetta Genomics Business Overview
7.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.8.4 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Rosetta Genomics Key News & Latest Developments
7.9 Exact Science Corporation
7.9.1 Exact Science Corporation Company Summary
7.9.2 Exact Science Corporation Business Overview
7.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.9.4 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Exact Science Corporation Key News & Latest Developments
7.10 Pathway Genomics Corporation
7.10.1 Pathway Genomics Corporation Company Summary
7.10.2 Pathway Genomics Corporation Business Overview
7.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.10.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Pathway Genomics Corporation Key News & Latest Developments
7.11 Taiho Pharma
7.11.1 Taiho Pharma Company Summary
7.11.2 Taiho Pharma Business Overview
7.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.11.4 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Taiho Pharma Key News & Latest Developments
7.12 Merck KGaA
7.12.1 Merck KGaA Company Summary
7.12.2 Merck KGaA Business Overview
7.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.12.4 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Merck KGaA Key News & Latest Developments
7.13 Amgen
7.13.1 Amgen Company Summary
7.13.2 Amgen Business Overview
7.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.13.4 Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Amgen Key News & Latest Developments
7.14 Takeda
7.14.1 Takeda Company Summary
7.14.2 Takeda Business Overview
7.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.14.4 Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.14.5 Takeda Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.15.4 Roche Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 Eli Lilly
7.16.1 Eli Lilly Company Summary
7.16.2 Eli Lilly Business Overview
7.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.16.4 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Eli Lilly Key News & Latest Developments
7.17 Sanofi
7.17.1 Sanofi Company Summary
7.17.2 Sanofi Business Overview
7.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.17.4 Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Sanofi Key News & Latest Developments
7.18 Regeneron
7.18.1 Regeneron Company Summary
7.18.2 Regeneron Business Overview
7.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.18.4 Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.18.5 Regeneron Key News & Latest Developments
7.19 Bayer
7.19.1 Bayer Company Summary
7.19.2 Bayer Business Overview
7.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.19.4 Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.19.5 Bayer Key News & Latest Developments
7.20 Onyx
7.20.1 Onyx Company Summary
7.20.2 Onyx Business Overview
7.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.20.4 Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.20.5 Onyx Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Colorectal Cancer Diagnostics & Therapeutics Market Opportunities & Trends in Global Market
Table 2. Colorectal Cancer Diagnostics & Therapeutics Market Drivers in Global Market
Table 3. Colorectal Cancer Diagnostics & Therapeutics Market Restraints in Global Market
Table 4. Key Players of Colorectal Cancer Diagnostics & Therapeutics in Global Market
Table 5. Top Colorectal Cancer Diagnostics & Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Colorectal Cancer Diagnostics & Therapeutics Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Diagnostics & Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Diagnostics & Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Colorectal Cancer Diagnostics & Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Colorectal Cancer Diagnostics & Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Colorectal Cancer Diagnostics & Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Colorectal Cancer Diagnostics & Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Biocept Company Summary
Table 31. Biocept Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 32. Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Biocept Key News & Latest Developments
Table 34. Cancer Genetics Company Summary
Table 35. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 36. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Cancer Genetics Key News & Latest Developments
Table 38. Foundation Medicine Company Summary
Table 39. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 40. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Foundation Medicine Key News & Latest Developments
Table 42. Sysmex Corporation Company Summary
Table 43. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 44. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Sysmex Corporation Key News & Latest Developments
Table 46. Danaher Corporation Company Summary
Table 47. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 48. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Danaher Corporation Key News & Latest Developments
Table 50. Epigenomics Company Summary
Table 51. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 52. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Epigenomics Key News & Latest Developments
Table 54. Illumina Company Summary
Table 55. Illumina Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 56. Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Illumina Key News & Latest Developments
Table 58. Rosetta Genomics Company Summary
Table 59. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 60. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Rosetta Genomics Key News & Latest Developments
Table 62. Exact Science Corporation Company Summary
Table 63. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 64. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Exact Science Corporation Key News & Latest Developments
Table 66. Pathway Genomics Corporation Company Summary
Table 67. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 68. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Pathway Genomics Corporation Key News & Latest Developments
Table 70. Taiho Pharma Company Summary
Table 71. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 72. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Taiho Pharma Key News & Latest Developments
Table 74. Merck KGaA Company Summary
Table 75. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 76. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Merck KGaA Key News & Latest Developments
Table 78. Amgen Company Summary
Table 79. Amgen Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 80. Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Amgen Key News & Latest Developments
Table 82. Takeda Company Summary
Table 83. Takeda Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 84. Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. Takeda Key News & Latest Developments
Table 86. Roche Company Summary
Table 87. Roche Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 88. Roche Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 89. Roche Key News & Latest Developments
Table 90. Eli Lilly Company Summary
Table 91. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 92. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 93. Eli Lilly Key News & Latest Developments
Table 94. Sanofi Company Summary
Table 95. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 96. Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 97. Sanofi Key News & Latest Developments
Table 98. Regeneron Company Summary
Table 99. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 100. Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 101. Regeneron Key News & Latest Developments
Table 102. Bayer Company Summary
Table 103. Bayer Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 104. Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 105. Bayer Key News & Latest Developments
Table 106. Onyx Company Summary
Table 107. Onyx Colorectal Cancer Diagnostics & Therapeutics Product Offerings
Table 108. Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 109. Onyx Key News & Latest Developments
List of Figures
Figure 1. Colorectal Cancer Diagnostics & Therapeutics Segment by Type in 2022
Figure 2. Colorectal Cancer Diagnostics & Therapeutics Segment by Application in 2022
Figure 3. Global Colorectal Cancer Diagnostics & Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2022
Figure 8. By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Colorectal Cancer Diagnostics & Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Roche Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
